Indiva (NDVA) Stock Price, News & Analysis

Company Overview

Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA, Indiva Life, and Artisan Batch brands. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Jewels Chewable Tarts, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.

Key Stats

• Today's Range: C$0.03 to C$0.04
• 50-Day Range: C$0.03 to C$0.03
• 52-Week Range: C$0.02 to C$0.13
• Volume: 558,384 shs
• Average Volume: 119,038 shs
• Market Capitalization: C$5.86 million
• P/E Ratio: N/A
• Dividend Yield: 4.04%
• Price Target: C$0.15
• Consensus Rating: Buy

Indiva Stock Analysis - MarketRank™

Indiva scored higher than 37% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Indiva has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Indiva has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Indiva is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Indiva is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for NDVA.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Indiva is a leading dividend payer. It pays a dividend yield of 4.04%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Indiva does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for NDVA.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Indiva this week, compared to 0 articles on an average week.

Search Interest

6 people have searched for NDVA on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Indiva insiders have not sold or bought any company stock.

Percentage Held by Insiders

36.29% of the stock of Indiva is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 0.06% of the stock of Indiva is held by institutions.

NDVA Stock Analysis - Frequently Asked Questions

How have NDVA shares performed this year?

Indiva's stock was trading at C$0.10 at the beginning of the year. Since then, NDVA shares have decreased by 68.4% and is now trading at C$0.03.
View the best growth stocks for 2024 here.

How do I buy shares of Indiva?

Shares of NDVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Indiva own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Indiva investors own include Meta Platforms (META), Canopy Growth (CGC), 22nd Century Group (XXII), AcelRx Pharmaceuticals (ACRX), Acasti Pharma (ACST), Curaleaf (CURLF) and Fortress Biotech (FBIO).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: CVE:NDVA
• CUSIP: N/A
• CIK: N/A
• Web: indiva.ca
• Phone: 888-649-6686
• Fax: N/A
• Employees: 147,000
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: C$0.15
• High Stock Price Target: C$0.15
• Low Stock Price Target: C$0.15
• Potential Upside/Downside: +400.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): C($0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-4,920,000.00
• Net Margins: -13.09%
• Pretax Margin: N/A
• Return on Equity: -544.76%
• Return on Assets: -3.51%

Debt

• Debt-to-Equity Ratio: 5,899.22
• Current Ratio: 0.72
• Quick Ratio: 0.52

Sales & Book Value

• Annual Sales: C$37.57 million
• Price / Sales: 0.16
• Cash Flow: C$0.01 per share
• Price / Cash Flow: 5.20
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 195,490,000
• Free Float: N/A
• Market Cap: C$5.86 million
• Optionable: Not Optionable
• Beta: 1.12